logo
Unusual Machines Secures $1.6 Million Order for Aura Cameras and HDO+ Goggles to Support U.S. Defense Supply Chain

Unusual Machines Secures $1.6 Million Order for Aura Cameras and HDO+ Goggles to Support U.S. Defense Supply Chain

Miami Heralda day ago
ORLANDO, FLORIDA / ACCESS Newswire / August 19, 2025 / Unusual Machines, Inc. (NYSE American:UMAC), a provider of NDAA-compliant drone components, today announced a $1.6 million purchase of Fat Shark Aura cameras and HDO+ goggles placed by a domestic defense drone manufacturer. The components will be delivered through the U.S. defense supply chain, reinforcing Unusual Machines' role as a trusted supplier of compliant equipment.
The Fat Shark Aura cameras are included in the Blue UAS Framework, confirming compliance with Department of Defense and NDAA standards. The HDO+ goggles offer high-clarity optics with the largest field of view of any analog FPV headset currently on the market, allowing operators to switch between 4:3 and 16:9 aspect ratios without narrowing the field of vision.
Production will begin immediately, with initial deliveries scheduled for the end of September and the remainder completed by December.
"This order represents a milestone for Unusual Machines and, importantly, reflects the trust our customers place in us to deliver large quantities of critical components," said Allan Evans, CEO of Unusual Machines. "By keeping cash reserves strong, scaling inventory ahead of demand, and strengthening our supply chain for larger volumes, we can execute quickly and reliably. This mindset allows us to accelerate delivery, ensure dependability, and expand manufacturing so more drone capability is built in the United States."
Today's announcement reflects the growing scale of opportunities for Unusual Machines. While this order will ship from existing production lines, the upcoming U.S.-based manufacturing facility for HDO+ goggles underscores the company's long-term strategy to onshore even more production, keep pace with government demand, and deliver the capacity needed for future growth.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. These statements include: our expectation that we will deliver initial orders of the Aura cameras and HDO+ goggles by the end of September 2025 and the balance of the orders by December 2025, our ability to execute orders, our quickly and reliably, and our expectation that we will be successful leasing a new facility and expand our manufacturing footprint and build our headset production capabilities. The results expected by some or all of these forward-looking statements may not occur. Factors that affect our ability to achieve these results include our expectation that we will commence operations in our new Orlando manufacturing facility in September 2025 and close the Rotor Lab acquisition in the third quarter of 2025, the continued availability of commercial real estate near our Orlando, Florida facilities, the availability of a satisfactory labor pool, potential supply chain issues, the impact from tariffs including inflation, and the Risk Factors contained in our Form 10-Q, filed with the SEC on May 8, 2025, Prospectus Supplement filed with the Securities and Exchange Commission (the "SEC") on March 6, 2025 and in our Form 10-K for the year ended December 31, 2024. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. Any forward-looking statement made by us herein speaks only as of the date on which it is made. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
About Unusual Machines
Unusual Machines manufactures and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in FPV (first-person view) ultra-low latency video goggles for drone pilots. The Company also retails small, acrobatic FPV drones and equipment directly to consumers through the curated Rotor Riot ecommerce store. With a changing regulatory environment, Unusual Machines seeks to be a dominant Tier-1 parts supplier to the fast-growing multi-billion-dollar U.S. drone industry. According to Fact.MR, the global drone accessories market is currently valued at $17.5 billion and is set to top $115 billion by 2032. For more information, please visit www.unusualmachines.com.
Investor Contact:
CS Investor Relationsinvestors@unusualmachines.com
Media Contact:
media@unusualmachines.com
SOURCE: Unusual Machines, Inc.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial
Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial

Yahoo

time40 minutes ago

  • Yahoo

Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial

Merck & Co., Inc. (NYSE:MRK) is included in our list of the . A dose bottle of the medication is in the medical tech's hand On August 12, 2025, Merck & Co., Inc. (NYSE:MRK) announced an update regarding its Phase 3 KEYNOTE-905 trial. According to the update, the trial met its primary and key secondary endpoints in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based chemotherapy. The study revealed improved event-free survival, overall survival, and pathologic complete response rates compared to surgery alone. The improved outcome was a result of giving patients KEYTRUDA (pembrolizumab) and Padcev (enfortumab vedotin-ejfv) medicines before and after surgery. The trial, carried out in collaboration with Pfizer and Astellas, marks the first systemic treatment that enhances survival rates in this patient group. Furthermore, no new side effects were observed. Operating through its Pharmaceutical and Animal Health segments, Merck & Co., Inc. (NYSE:MRK) leads as a healthcare company worldwide. It is included in our list of the most undervalued value stocks to buy. While we acknowledge the potential of MRK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Oil Refinery Stocks to Buy Right Now and 7 Best Potash Stocks to Buy According to Analysts. Disclosure: None.

Cantor Equity Partners IV, Inc. Announces Pricing of $400 Million Initial Public Offering
Cantor Equity Partners IV, Inc. Announces Pricing of $400 Million Initial Public Offering

Business Wire

time4 hours ago

  • Business Wire

Cantor Equity Partners IV, Inc. Announces Pricing of $400 Million Initial Public Offering

NEW YORK--(BUSINESS WIRE)--Cantor Equity Partners IV, Inc. (Nasdaq: CEPF) (the 'Company') announced today the pricing of its initial public offering of 40,000,000 Class A ordinary shares at $10.00 per share. The shares are expected to be listed on the Nasdaq Global Market under the symbol 'CEPF' and begin trading on August 21, 2025. The underwriters have been granted a 45-day option to purchase up to an additional 6,000,000 shares offered by the Company to cover over-allotments, if any. The offering is expected to close on August 22, 2025, subject to customary closing conditions. Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering. About Cantor Equity Partners IV, Inc. Cantor Equity Partners IV, Inc. is a blank check company sponsored by Cantor Fitzgerald and led by Chairman and Chief Executive Officer Brandon Lutnick. Cantor Equity Partners IV, Inc. was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company's efforts to identify a prospective target business will not be limited to a particular industry or geographic region, but the Company intends to focus on a target in an industry where it believes the Company's management teams' and affiliates' expertise will provide the Company with a competitive advantage, including the financial services, digital assets, healthcare, real estate services, technology and software industries. A registration statement relating to these securities was declared effective by the Securities and Exchange Commission (the 'SEC') on August 20, 2025. The offering is being made only by means of a prospectus, copies of which may be obtained by contacting Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, 6th Floor New York, New York 10022; Email: prospectus@ Copies of the registration statement can be accessed through the SEC's website at This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Forward-Looking Statements This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, including with respect to the successful consummation of the Company's initial public offering and use of the net proceeds of the offering as described in the offering prospectus, are subject to risks and uncertainties including those set forth in the Risk Factors section of the Company's registration statement for the offering filed with the SEC, which could cause actual results to differ from the forward-looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Pioneer High Income Fund, Inc. Announces Results of Special Meeting of Stockholders: Proposal to Liquidate and Dissolve the Fund is Approved
Pioneer High Income Fund, Inc. Announces Results of Special Meeting of Stockholders: Proposal to Liquidate and Dissolve the Fund is Approved

Business Wire

time4 hours ago

  • Business Wire

Pioneer High Income Fund, Inc. Announces Results of Special Meeting of Stockholders: Proposal to Liquidate and Dissolve the Fund is Approved

BOSTON--(BUSINESS WIRE)--Pioneer High Income Fund, Inc. (PHT) announced the results of its special meeting of stockholders originally held on July 17, 2025, adjourned until August 13, 2025, and further adjourned until August 20, 2025. At the fund's special meeting, stockholders approved the liquidation and dissolution of the fund pursuant to the Plan of Liquidation and Dissolution adopted by the Board of Directors of the fund. Pursuant to the Plan, the fund will liquidate its portfolio in preparation for one or more distributions of cash to the stockholders of the fund. Once the fund commences liquidating its portfolio, the fund may not pursue its stated investment objective, comply with its investment limitations or engage in normal business activities, except for the purposes of winding up its business and affairs, paying its liabilities and distributing its remaining assets to stockholders. The fund plans to direct the transfer agent to close the books on its shares at the close of business on September 25, 2025 (the 'Determination Date'). The proportionate interests of stockholders in the assets of the fund will be fixed on the basis of their respective holdings at the close of business on the Determination Date. The fund also expects that the last day of secondary market trading of the fund's shares also will be on or about the Determination Date. Accordingly, it is expected that prior to the opening of business on September 26, 2025, the fund will cease trading on the NYSE. The distribution to shareholders of liquidation proceeds will occur as soon as practicable following the Determination Date. The fund expects to make a primary distribution of liquidation proceeds to its stockholders on or about September 30, 2025. The proceeds of the liquidation of the fund will equal the fund's net asset value after the fund has paid or provided for all of its charges, taxes, expenses and liabilities, including certain costs associated with liquidating the fund. As necessary, the fund may make one or more liquidating distributions after it makes the primary liquidating distribution. Upon payment of the final liquidating distribution by the fund, all outstanding shares of the fund will be redeemed without the imposition of any redemption or other transaction fees. The liquidation will generally be a taxable event for stockholders that are subject to U.S. federal income tax. Any such stockholder that receives a distribution in a liquidation will generally realize a capital gain or loss in an amount equal to the difference between the total amount of the liquidation distribution(s) received and the stockholder's adjusted basis in the fund shares. Please consult your personal tax advisor with regard to the specific tax consequences of the liquidation. The fund expects that stockholders will be able to sell their fund shares in the secondary market until the market close on or about the Determination Date. The sale of fund shares in the secondary market will generally be a taxable event for stockholders that are subject to U.S. federal income tax. In addition, customary brokerage charges may apply to such transactions. The fund expects that, effective as of market close on or about the Determination Date, the fund's shares will no longer be actively traded in the secondary market, and there can be no assurance that there will, thereafter, be a market for the purchase or sale of the fund's shares. PHT is a closed-end investment company that trades on the New York Stock Exchange (NYSE). Investments involve risk including possible loss of principal, and an investment should be made with an understanding of the risks involved with owning a particular security or asset class. Interested parties are strongly encouraged to seek advice from qualified tax and financial experts regarding the best options for your particular circumstances. Victory Capital Services, Inc. Keep in mind, distribution rates are not guaranteed. A fund's distribution rate may be affected by numerous factors, including changes in actual or projected investment income, the level of undistributed net investment income, if any, and other factors. Shareholders should not draw any conclusions about a fund's investment performance based on a fund's current distributions. Closed-end funds, unlike open-end funds, are not continuously offered. Once issued, common shares of closed-end funds are bought and sold in the open market through a stock exchange and frequently trade at prices lower than their net asset value. Net Asset Value (NAV) is total assets less total liabilities divided by the number of common shares outstanding. For performance data on Pioneer Investments' closed-end funds, please call 800-225-6292 or visit our closed-end pricing page.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store